Navigation Links
IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals
Date:11/8/2013

over 45x 2013E sales after factoring options/RSUs, critiques of its valuation are easy to find today.

Vale SA (NYSE: VALE) says it is looking at ways to tie up its nickel operations in Canada's Sudbury basin with those of nearby producers such as Glencore Xstrata, likely taking the form of an "unincorporated" joint venture in the mining, milling and smelting segments of nickel production.

How Should Investors Trade VALE After The Recent Volatility? Find Out Here http://marketbuzzreport.com/index.php?code=VALE (Or Copy and paste the URL into your browser)

Vale says it has sought synergies in the Sudbury basin constantly since 2006 but stagnant nickel prices appear to have given new impetus to the effort; Barclays estimates nickel prices will average $15,173/ton this year, down from $22,853 in 2011.

After dropping 58% on Monday and Tuesday in the absence of any major news, OCZ Technology Group Inc.(NASDAQ: OCZ) has rallied 69% over the last two days. Altogether, shares remain down 29% from their Friday close, and 42% from where they traded before OCZ's Oct. 15 FQ2 report, within which the SSD vendor disclosed it ended its August quarter with only $10.6M in cash.

Free Urgent Insider Catalyst Report For OCZ Available Here: http://marketbuzzreport.com/index.php?code=OCZ (Or Copy and paste the URL into your browser)

This morning, OCZ unveiled its Vector 150 PC SSD line. The company asserts its use of 19nm NAND flash chips and its home-grown Barefoot 3 controller IC yields superior performance relative to prior-gen drives; reviews are generally positive. However, OCZ has carried out similar product lau
'/>"/>

SOURCE FN Media Group, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
2. Preliminary Figures for 2011: Sartorius Grows at Double-Digit Rates and Boosts Operating Earnings by More Than 30%
3. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
4. WuXi PharmaTech Schedules Second-Quarter 2012 Earnings Release
5. Life Technologies Sets 2nd Quarter 2012 Earnings Release Date for Tuesday, July 31, 2012
6. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
7. Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations
8. Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
9. Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
10. Zynga, Inc. Fourth-Quarter Earnings and Sales Topped Wall Street Estimates
11. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... company focused on the development of autologous cell ... the International Society for Cellular Therapy (ISCT) on ... currently in a Phase 1/2 clinical trial.  The ... from 5:30 PM to 7:00 PM local time, ...
(Date:5/20/2015)... SAN FRANCISCO, Calif. , May 20, 2015 ... VCYT ) today presented preliminary data demonstrating the ... distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial ... The findings suggest the classifier,s potential to help ... surgery to resolve ambiguity in IPF diagnosis – ...
(Date:5/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) ... Therapy Market Outlook 2020 " report to their ... and regenerative medicine is expected to have huge marketing ... help in the growth of deregulated organs. Several therapeutic ... unable to form new tissue or sometimes organ transplant ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... Diagnostics Inc.,(TSX: SDI) today announced that its Endotoxin ... of sepsis, will be used to measure,endotoxin levels ... III sub study,part of a multinational clinical trial ... severe sepsis., "Spectral is pleased that a ...
... Cytopia Limited,(ASX: CYT) today announced that it is ... Association for Cancer Research Annual Meeting being held,in ... from around the world to discuss new and ... "A Novel JAK2 inhibitor for the treatment of,myeloproliferative ...
... Blacksburg, Va. -- Fullerenes, also fondly known as buckyballs, ... 1985, the hollow carbon atoms have been adapted for ... of imaging materials. , It appears that the ... water, forming aggregates of thousands of molecules. And there ...
Cached Biology Technology:Spectral's EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy 2Citrate appears to control buckyball clumping but environmental concerns remain 2Citrate appears to control buckyball clumping but environmental concerns remain 3
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
... 14, 2013 -- The following statement was issued today by ... Society (WCS) today celebrates the decision by an historic, broad ... new sharks, freshwater sawfish, and two manta ray species for ... of Wild Fauna and Flora (CITES). This vote is a ...
... used synonymously with "boring," as in that story or ... biology seeking to engineer valuable new microbes, however, predictability ... with the multi-institutional partnership known as BIOFAB have become ... this ring by unveiling a package of public domain ...
... MWG Operon and School of Biological and Chemical Sciences, Queen ... on the genome sequencing analysis of Ash ( Fraxinus excelsior ... our understanding of the wide spreading fungal tree disease ... northern Europe and has already been found at more than ...
Cached Biology News:Predictability: The brass ring for synthetic biology 2Eurofins MWG Operon and Queen Mary, University Of London commence genome sequencing analysis of Ash 2
Request Info...
Recombinant Mouse sTNF RII/TNFRSF1B...
One-step, microplate or cuvet, colorimetric, linear detection range 0.2 mg/dL to 20 mg/dL. Procedure: 20 min....
Mouse Wnt-11 Affinity Purified Polyclonal Ab...
Biology Products: